Neo-Lanicor en es it fr

Neo-Lanicor Brand names, Neo-Lanicor Analogs

Neo-Lanicor Brand Names Mixture

  • No information avaliable

Neo-Lanicor Chemical_Formula


Neo-Lanicor RX_link

Neo-Lanicor fda sheet

Neo-Lanicor FDA

Neo-Lanicor msds (material safety sheet)

Neo-Lanicor MSDS

Neo-Lanicor Synthesis Reference

S. Smith, J. Chem. Soc. 1930, 508

Neo-Lanicor Molecular Weight

780.938 g/mol

Neo-Lanicor Melting Point

248-250 oC

Neo-Lanicor H2O Solubility


Neo-Lanicor State


Neo-Lanicor LogP


Neo-Lanicor Dosage Forms

Tablet; Capsule; Injection

Neo-Lanicor Indication

For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.

Neo-Lanicor Pharmacology

Digoxin, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation.

Neo-Lanicor Absorption

Absorption of digoxin from the elixir pediatric formulation has been demonstrated to be 70% to 85% complete (90% to 100% from the capsules, and 60% to 80% for tablets).

Neo-Lanicor side effects and Toxicity

Toxicity includes ventricular tachycardia or ventricular fibrillation, or progressive bradyarrhythmias, or heart block. LD50 = 7.8 mg/kg (orally in mice).

Neo-Lanicor Patient Information

Digoxin is used for the treatment of congestive heart failure and for irregular heartbeat. Notify your physician if you are pregnant or nursing. Do not stop taking digoxin without talking with your physician. Digoxin may be taken with or without food. It should be taken at approximately the same time each morning. Do not take over-the-counter antacids, cough, cold, allergy or diet medications without notifying your physician and pharmacist. Notify your physician if you develop an irregular heartbeat, trouble breathing, skin rash, nausea, diarrhea, blurred or yellow vision, or unusual weakness or tiredness.

Neo-Lanicor Organisms Affected

Humans and other mammals